Promotion Agreement Dated December 10, 2018

Exagen

28/12/2020 21:17

Dec 28 (Reuters) - Exagen Inc  XGN.O :
    * EXAGEN INC -  ON DECEMBER 23, CO AND JANSSEN BIOTECH
ENTERED
INTO AN AMENDMENT TO THE CO-PROMOTION AGREEMENT DATED DECEMBER
10, 2018
    * EXAGEN INC - PREDETERMINED AVERAGE BASELINE FOR TOTAL
PRESCRIBED
UNITS OF SIMPONI(REG) FOR 3 QTRS WAS ADJUSTED TO ABOUT 28,750
PRESCRIBED UNITS/QUARTER
    * EXAGEN INC - PURSUANT TO AMENDMENT, FOR EACH OF FIRST AND
SECOND
QUARTERS OF 2021, CO WILL RECEIVE A MINIMUM PROMOTION FEE OF
$0.3 MILLION
    * EXAGEN INC -  FOR EACH OF FIRST AND SECOND QUARTERS OF
2021,
MINIMUM PROMOTION FEE WILL BE CAPPED AT 10% ABOVE ADJUSTED
PREDETERMINED BASELINE
    * EXAGEN - QUARTERLY TIERED PROMOTION FEE FOR REMAINING TERM
OF
AGREEMENT BEGINNING QUARTER ENDED SEPT 30, 2021 WILL REVERT TO
TERMS SET FORTH IN AGREEMENT

Source : (https://bit.ly/3mZsKYa)
Further company coverage:  XGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))